Home »
PE/VC Activity in Medical Devices - Number of PE/VC Investments in Small Sized Medical Devices Companies has Increased in the Past Four Years

PE/VC Activity in Medical Devices - Number of PE/VC Investments in Small Sized Medical Devices Companies has Increased in the Past Four Years

Double click on above image to view full picture

Email to a Colleague - Print - Fax Order

Additional Information

Price	$3,500.00
Publisher	GBI Research
Date of Report	Jan 7, 2011

Add to Wishlist | Add to Compare

Qty:

-OR-

Quick Overview

PE/VC Activity in Medical Devices - Number of PE/VC Investments in Small Sized Medical Devices Companies has Increased in the Past Four Years

Summary

GBI Research’s report, “PE/VC Activity in Medical Devices - Number of PE/VC Investments in Small Sized Medical Devices Companies has Increased in the Past Four Years” provides key data, information and analysis on the global medical devices market. The report provides private equity and venture capital (PE/VC) activity in 18 medical device market categories – In Vitro Diagnostics, Cardiovascular Devices, Orthopedic Devices, Anesthesia and Respiratory Devices, Dental Devices, Diabetes Care devices, Diagnostic Imaging, Drug Delivery Devices, Endoscopy Devices, Ear, Nose and Throat Devices, Healthcare IT, Hospital Supplies, Nephrology and Urology, Neurology Devices, Ophthalmic Devices, Patient Monitoring, Surgical Equipment and Wound Care Management. The report provides comprehensive information on the factors affecting PE/VC investment in these categories. The report also reviews the detailed analysis of the PE/VC deals worth greater than $100m in each category. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

- Key geographies covered include North America, Europe and the Asia-Pacific.
- PE/VC activity in the following market categories – In Vitro Diagnostics, Cardiovascular Devices, Orthopedic Devices, Anesthesia and Respiratory Devices, Dental Devices, Diabetes Care devices, Diagnostic Imaging, Drug Delivery Devices, Endoscopy Devices, ENT Devices, Healthcare IT, Hospital Supplies, Nephrology and Urology, Neurology Devices, Ophthalmic Devices, Patient Monitoring, Surgical Equipment and Wound Care Management
- PE/VC deals from 2007 to 2010 in the medical device market and detailed analysis of deals greater than $100m in size.
- The report also covers top financial advisors for the PE/VC deals from 2007 to 2010 in the medical device market.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the medical devices market globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit PE/VC opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return.
- What’s the next big thing in the PE/VC activity in medical devices landscape? Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global medical devices market and the factors shaping it.

Table of Contents

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 9
2.1 GBI Research Report Guidance 9
3 PE/VC Deals Summary in the Medical Device Industry 10
3.1 PE/VC Deals by Number and Deal Value, 2007–2010 10
3.2 Segmentation of PE/VC Deals by Stages, 2007–2010 11
3.2.1 Conclusion 12
3.3 Withdrawn/Terminated Deals 12
3.3.1 Ion Beam Applications Terminated Sale of Its BioAssays Unit 13
3.3.2 Smiths Group Rejects Cash Bid of Apax Partners for Smiths Medical 13
3.3.3 Ares Life Sciences, Essex, Intesa and Alpha Terminated Acquisition of Sorin 14
3.3.4 AMICAS Terminated Acquisition with Thoma Bravo 14
3.3.5 Q-Med Terminated Offer for Its Acquisition by Ivytan 15
3.3.6 Endologix Terminated Offer for Its Acquisition by Elliot Associates 15
3.3.7 Conclusion 16
4 PE/VC Deals in Medical Devices by Geography 17
4.1 PE/VC Deals in North America 17
4.2 PE/VC Deals in Europe 19
4.3 PE/VC Deals in the Asia-Pacific 21
4.3.1 Conclusion 22
5 PE/VC Activity in Medical Devices by Market 23
5.1 In Vitro Diagnostics 23
5.1.1 Deals Analysis 24
5.1.2 PE/VC Deals - In Vitro Diagnostics 24
5.1.3 Pacific Biosciences Secured Additional $59m in Series F Round of Financing 25
5.1.4 Legal & General Ventures Sells LGC to Bridgepoint 25
5.1.5 Welsh, Carson, Anderson & Stowe Acquired Spectrum Laboratory Network from Apax Partners 26
5.1.6 Bridgepoint Capital Acquired Terveystalo Healthcare 27
5.1.7 Duke Street Acquired Biomnis 27
5.1.8 The EQT V fund Acquired Dako Denmark 28
5.2 Cardiovascular Devices 29
5.2.1 Deal Analysis 30
5.2.2 Ares Life Sciences Acquired Stake in Esaote 30
5.2.3 Boston Scientific Sells Fluid Management and Venous Access Businesses To Avista Capital 31
5.2.4 Cardionet Secures $110m in Series E Financing 32
5.3 Orthopedic Devices 33
5.3.1 Deals Analysis 34
5.3.2 Small Bone Innovations Secured $108m in Series D Financing 36
5.3.3 Globus Medical Secures $110m Series E Financing 36
5.4 Anesthesia and Respiratory Devices 38
5.4.1 Deals Analysis 39
5.4.2 Water Street Healthcare Acquires Stake in CareCentrix from Gentiva Health 39
5.5 Dental Devices 40
5.5.1 Deals Analysis 41
5.5.2 TA Associates Acquired Stake in Amann Girrbach 41
5.5.3 Palamon Capital Partners Completes Acquisition of Associated Dental Partners 42
5.6 Diabetes Care Devices 43
5.6.1 Deals Analysis 44
5.6.2 The Blackstone Group Acquires Apria Healthcare 44
5.7 Diagnostic Imaging 45
5.7.1 Deals Analysis 46
5.7.2 Bridgepoint Capital Acquired Terveystalo Healthcare 46
5.7.3 Merrill Lynch and Ares Acquires Euromedic from Warburg Pincus 47
5.7.4 Avista Capital Partners Acquired Bristol-Myers Squibb Medical Imaging 48
5.7.5 Dubai International Capital Acquired Alliance Medical from Bridgepoint Capital 48
5.7.6 DeA Capital and Mediobanca Acquired 53% Majority Stake in Generale de Sante 49
5.8 Drug Delivery Devices 50
5.8.1 Deals Analysis 51
5.8.2 Warburg Pincus Acquired Lifecore Biomedical 51
5.9 Endoscopy Devices 52
5.9.1 Deals Analysis 53
5.9.2 TPG Capital Acquires Axcan Pharma 53
5.10 Ear, Nose and Throat (ENT) Devices 54
5.10.1 Deals Analysis 55
5.10.2 Technitrol Sells Medtech Component Business To Altor 55
5.11 Healthcare IT 56
5.11.1 Huntsman Gay Global Acquires 51% Stake in Sunquest Information from Vista Equity Partners 58
5.11.2 BC Partners and Silver Lake Acquires MultiPlan from the Carlyle Group and Welsh, Carson, Anderson & Stowe 58
5.11.3 OMERS Private Equity Completes Acquisition of Logibec Groupe Informatique 59
5.11.4 Francisco Partners Completes Acquisition Of Quadramed 60
5.11.5 ikaSystems Received Additional Investment From Essex Woodlands Health 61
5.11.6 Truveris Raises $3.8m in First Venture Financing Round 61
5.11.7 Glocal Healthcare Systems to Raise $3.25m in Venture Financing 62
5.11.8 Apax Partners, Bluecross Blueshield and Regence Group Acquired the TriZetto Group 62
5.11.9 Merrill Lynch and Ares Acquired Euromedic From Warburg Pincus 63
5.11.10 General Atlantic And Hellman & Friedman Acquires Remaining 48% Stake In Emdeon Business Services From HLTH 64
5.11.11 TA Associates Acquired Alere Medical 64
5.12 Hospital Supplies 66
5.12.1 Deals Analysis 67
5.12.2 The Blackstone Group Completes Acquisition of Polymer Group 67
5.12.3 EQT Partners Completed Acquisition of HTL-Strefa 68
5.12.4 Lehman Brothers Acquired Angelica 68
5.12.5 Tenet Healthcare Sells Its Majority Stake in Broadlane to TowerBrook Capital Partners 69
5.13 Nephrology and Urology Devices 70
5.13.1 Deals Analysis 71
5.13.2 Merrill Lynch and Ares Acquired Euromedic from Warburg Pincus 71
5.14 Neurology Devices 72
5.14.1 Deals Analysis 73
5.15 Ophthalmic Devices 73
5.15.1 3i Acquired Ultralase from Corporacion Dermoestetica 74
5.15.2 Warburg Pincus Acquired Bausch & Lomb 75
5.16 Patient Monitoring 76
5.16.1 Deals Analysis 77
5.16.2 TA Associates Acquired Alere Medical 77
5.17 Surgical Equipment 78
5.17.1 Deals Analysis 79
5.17.2 PerkinElmer Sells Illumination and Detection Solutions Business to Veritas Capital Fund Management 79
5.17.3 HLTH Sells Porex to Aurora Capital 80
5.18 Wound Care Management 81
5.18.2 Investor Acquired 34% Stake in Molnlycke Health Care 82
5.18.3 Nordic Capital Fund and Avista Capital Partners Acquire ConvaTec from Bristol-Myers Squibb 83
5.18.4 Investor and Morgan Stanley Completed Acquisition of Molnlycke Health Care from Apax Partners 84
6 Global Medical Devices, Top Financial Advisors 86
6.1 Top Financial Advisors, PE/VC Deals Medical Devices 86
7 PE/VC Activity in Medical Devices- Appendix 87
7.1 Acronyms 87
7.2 Research Methodology 88
7.2.1 Secondary Research 88
7.2.2 Primary Research 88
7.2.3 Models 89
7.2.4 Forecasts 89
7.2.5 Expert Panels 89
7.3 Contact Us 89
7.4 Disclaimer 90
7.5 Sources 90